Analysis of hepatitis B virus in patients after liver transplantation
Project/Area Number |
23590972
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Kyoto University |
Principal Investigator |
UEDA Yoshihide 京都大学, 医学(系)研究科(研究院), 講師 (90378662)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | B型肝炎 / 肝移植 / 免疫抑制 |
Research Abstract |
Hepatitis B virus (HBV) infected in individuals who are negative for hepatitis B surface antigen (HBsAg) but positive for hepatitis B core antibody (anti-HBc), which is indicative of resolved hepatitis B, was analyzed. De novo activation of HBV frequently occurred after liver transplantation from HBsAg-negative and anti-HBc-positive donors due to the emergence of HBV with escape mutations from hepatitis B surface antibody. Moreover, ultra-deep sequencing revealed that the genetic heterogeneity of reactivated HBV in immunosuppressive condition was significantly lower in patients with reactivation from occult HBV carrier status compared with that in patients from HBsAg carrier status.
|
Report
(4 results)
Research Products
(32 results)
-
-
[Journal Article] Chronic rejection associated with antiviral therapy for recurrent hepatitis C after living-donor liver transplantation2014
Author(s)
Ueda Y, Kaido T, Ito T, Ogawa K, Yoshizawa A, Fujimoto Y, Mori A, Miyagawa-Hayashino A, Haga H, Marusawa H, Chiba T, Uemoto
-
Journal Title
Transplantation
Volume: 97
Issue: 3
Pages: 344-350
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Efficacy and safety of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living donor liver transplantation2013
Author(s)
Ueda Y, Marusawa H, Kaido T, Ogura Y, Ogawa K, Yoshizawa A, Hata K, Fujimoto Y, Nishijima N, Chiba T, Uemoto S
-
Journal Title
Hepatol Res
Volume: 43
Issue: 1
Pages: 67-71
DOI
NAID
Related Report
-
[Journal Article] Pretransplant serum hepatitis C virus RNA levels predict response to antiviral treatment after living donor liver transplantation2013
Author(s)
Ueda Y, Kaido T, Ogura Y, Ogawa K, Yoshizawa A, Hata K, Fujimoto Y, Miyagawa-Hayashino A, Haga H, Marusawa H, Teramukai S, Uemoto S, Chiba T
-
Journal Title
PLoS One
Volume: 8(3)
Issue: 3
Pages: e58380-e58380
DOI
NAID
Related Report
-
-
-
[Journal Article] Effect of maintenance therapy with low-dose peginterferon for recurrent hepatitis C after living donor liver transplantation2012
Author(s)
Ueda Y, Marusawa H, Kaido T, Ogura Y, Oike F, Mori A, Ogawa K, Yoshizawa A, Hatano E, Miyagawa-Hayashino A, Haga H, Egawa H, Takada Y, Uemoto S, Chiba T
-
Journal Title
J Viral Hepat
Volume: 19
Issue: 1
Pages: 32-38
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
[Journal Article] Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing2011
Author(s)
Nasu A, Marusawa H, Ueda Y, Nishijima N, Takahashi K, Osaki Y, Yamashita Y, Inokuma T, Tamada T, Fujiwara T, Sato F, Shimizu K, Chiba T
-
Journal Title
PLoS One
Volume: 6
Issue: 9
Pages: e24907-e24907
DOI
NAID
Related Report
Peer Reviewed
-
-
-
-
[Presentation] Safety and efficacy of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living donor liver transplantation2011
Author(s)
Yoshihide Ueda, Hiroyuki Marusawa, Toshimi Kaido, Yasuhiro Ogura, Kohei Ogawa, Atsushi Yoshizawa, Koichiro Hata, Tsutomu Chiba, Shinji Uemoto
Organizer
The American Association for the Study of Liver Diseases 62th annual meeting
Place of Presentation
San Francisco, CA, USA
Year and Date
2011-11-05
Related Report
-
-
-
-
-
-
-
[Presentation] Safety and efficacy of prophylaxis with entecavir and hepatitis B immunoglobulin in preventing hepatitis B recurrence after living donor liver transplantation.2011
Author(s)
Ueda, Y, Marusawa H, Kaido T, Ogura Y, Ogawa K, Yoshizawa A, Hata K, Chiba T, Uemoto S.
Organizer
The American Association for the Study of Liver Diseases 62th annual meeting
Place of Presentation
San Francisco, CA, USA.
Related Report
-
-
-
-
-
-
-